Mettler-Toledo International, Inc. (MTD)
ROA
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | 788 778 | 869 818 | 888 784 | 886 927 | 872 502 | 837 539 | 820 630 | 793 323 |
| Aktywa razem | w tys. USD | 3 355 560 | 3 288 730 | 3 370 400 | 3 409 910 | 3 492 400 | 3 294 460 | 3 336 430 | 3 356 180 |
| ROA | 23,51% | 26,45% | 26,37% | 26,01% | 24,98% | 25,42% | 24,60% | 23,64% |
2023/Q4 obliczenia
ROA = Zysk netto (ttm) ÷ Aktywa razem
= $788 778K ÷ $3 355 560K
= 23,51%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROA
Mettler-Toledo International, Inc.
MTD
23,51%
Agilent Technologies Inc.
A
11,29%
Bio-Rad Laboratories Inc.
BIO
-5,18%
Bruker Corp
BRKR
10,05%
Cytek BioSciences Inc
CTKB
-2,46%
Illumina Inc
ILMN
-11,48%
Integra Lifesciences Holdings Corp
IART
1,79%
Revvity Inc.
RVTY
5,11%
Waters Corp.
WAT
13,88%